Thursday, March 15, 2018

Pharma Reviews: India's leadership in cost-efficient generics is unchallenged: Sanjiv Kaul

ChrysCapital invested $20 million in dermatology product maker Curatio Healthcare early this week, making it the 10th investment of the homegrown PE firm into Indian Pharma. Sanjiv Kaul, partner at the PE firm, has spent over 40 years in Indian pharma, including a 27-year stint in various leadership ...
Read more: India's leadership in cost-efficient generics is unchallenged: Sanjiv Kaul